Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy
Clinical trial NCT02570789 · TERMINATED
Trial details
- NCT number
- NCT02570789
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.